| Madonna Smith, OTR/L | |
|
150 N Miller Rd, Ste 150a, Fairlawn, OH 44333-3770 | |
| (330) 867-2240 | |
| (330) 630-3198 |
| Full Name | Madonna Smith |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 150 N Miller Rd, Fairlawn, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215461496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT009723 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madonna Smith, OTR/L 150 N Miller Rd, Ste 150a, Fairlawn, OH 44333-3770 Ph: (330) 867-2240 | Madonna Smith, OTR/L 150 N Miller Rd, Ste 150a, Fairlawn, OH 44333-3770 Ph: (330) 867-2240 |
News Archive
A new study shows that a test physicians commonly used to guide chemotherapy treatment for post-breast cancer surgery patients may also help them decide whether radiation therapy may be of benefit.
OsteoSymbionics, innovative designer and manufacturer of patient-specific craniofacial implants, is pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance for sterile processing of its signature ClearShield™ cranial implant product, utilizing a novel room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process.
On 3rd September, Bedfont hosted a virtual launch party to open their first overseas office, Bedfont GmbH, based in Salzburg, Austria. Earlier this year Bedfont announced the acquisition of its former distributor, Dr Lahner Medizintechnik, which now serves as the new GmbH headquarters.
Reporting of radiation therapy details in randomized controlled trials for Hodgkin's and non-Hodgkin's lymphoma is deficient due to a lack of reporting of key radiation therapy descriptors and quality assurance processes designed to ensure the accuracy and reproducibility of treatment regimens, according to a February 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 4 days ago
Dr. Ryan A Domer, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 S Cleveland Massillon Rd, Fairlawn, OH 44333 Phone: 330-666-5866 | |
Brittany Stout, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd, #150a, Fairlawn, OH 44333 Phone: 330-867-2240 | |
Kelsey Moyra Washko, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Road, Suite 150a, Fairlawn, OH 44333 Phone: 216-219-0659 | |
Meredith Santiago, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 61 N Cleveland Massillon Rd, B, Fairlawn, OH 44333 Phone: 330-668-4041 Fax: 330-666-5626 | |
Deanna Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 | |
Ms. Elizabeth Grace Swope, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Baker Blvd, Suite1, Fairlawn, OH 44333 Phone: 330-865-1600 |